Lung Cancer

Few Eligible Smokers Had Lung Cancer Screening in 2016

Few Eligible Smokers Had Lung Cancer Screening in 2016

The most eligible smokers were populated in South, which had most screening sites but the low screening rates

Risk Models Help Select Ever Smokers for Lung Cancer Screening

Risk Models Help Select Ever Smokers for Lung Cancer Screening

Four models were well-calibrated and had higher areas under the curve than 5 models that overestimated lung cancer risk.

CKAP4 Is Novel Serodiagnostic Marker for Lung Cancer

CKAP4 Is Novel Serodiagnostic Marker for Lung Cancer

Serum CKAP4 levels of lung cancer patients were significantly higher than those of healthy controls.

Cancer Incidences and Burden Expected to Shift in HIV-Positive

Cancer Incidences and Burden Expected to Shift in HIV-Positive

Prostate and lung cancer expected to emerge as the most common types by 2030.

Clinical Upstaging of NSCLC Seen With Each Progressive Week

Clinical Upstaging of NSCLC Seen With Each Progressive Week

For clinical stage 1 non-small-cell lung cancer, 21.7% of patients upstaged after 1 week and 31.5% after 8 weeks.

Polypharmacy More Likely for Cancer Survivors

Polypharmacy More Likely for Cancer Survivors

More cancer survivors prescribed 5 or more unique medications, including medications with abuse potential.

A Potential Algorithm for Diagnosing Cavitary Lung Diseases

A Potential Algorithm for Diagnosing Cavitary Lung Diseases

By

Researchers developed an algorithmic approach to diagnosing lung cavitary diseases.

Adjuvant Pembrolizumab Beneficial in Metastatic NSCLC

Adjuvant Pembrolizumab Beneficial in Metastatic NSCLC

Nivolumab plus ipilimumab linked to better survival in NSCLC with high tumor mutational burden.

Most Patients Are Unaware of Cancer Drug Shortages

Most Patients Are Unaware of Cancer Drug Shortages

Majority of patients say they want to know about even minor consequences of cancer drug substitutions.

Dacomitinib Granted Priority Review for NSCLC With EGFR-Activating Mutations

Dacomitinib Granted Priority Review for NSCLC With EGFR-Activating Mutations

By

Dacomitinib is a pan-human epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.

Lag in Progress Against Lung Cancer Mortality in Midwest, Appalachia

Lag in Progress Against Lung Cancer Mortality in Midwest, Appalachia

Findings based on rates in women vs steady decline seen nationally.

Benign Lung Nodules Identified Using Proteomic Biomarker

Benign Lung Nodules Identified Using Proteomic Biomarker

By

An integrated proteomic classifier accurately identified benign lung nodules when used in patients with a pretest probability of malignancy ≤50%.

Lung Cancer Risk May Be Predicted by Frequency of COPD Exacerbations

Lung Cancer Risk May Be Predicted by Frequency of COPD Exacerbations

By

Independent predictive factors of lung cancer in chronic obstructive pulmonary disease may include frequency of exacerbations, in addition to airflow obstruction and visual emphysema.

COPD, Respiratory Symptoms Associated With "Western" Diet

COPD, Respiratory Symptoms Associated With "Western" Diet

Researchers used data from the Atherosclerosis Risk in Communities Study to assess associations between dietary pattern and pulmonary assessments.

Infused Chemotherapy Trends During 10-Year Period

Infused Chemotherapy Trends During 10-Year Period

During a 10-year period, there was an increase in the rate of commercially insured patients receiving infused chemotherapy in hospital outpatient departments.

Exercise May Improve Quality of Life in Lung Cancer

Exercise May Improve Quality of Life in Lung Cancer

By

Study examines increased physical activity may lower the risk for several cancers and may be beneficial for improving quality of life.

Lung Cancer Screening: Updated Guidelines From CHEST

Lung Cancer Screening: Updated Guidelines From CHEST

By

A CHEST expert panel has released updated guidelines for lung cancer screening.

Lung Cancer Postoperative Complications Reduced With Preoperative Exercise

Lung Cancer Postoperative Complications Reduced With Preoperative Exercise

Patients who underwent lung resections had reduced postoperative complication rates when they participated in preoperative exercise.

Early-Stage Non-Small Cell Lung Cancer Mortality With Surgery vs Radiotherapy

Early-Stage Non-Small Cell Lung Cancer Mortality With Surgery vs Radiotherapy

Mortality rates are higher after surgery vs stereotactic body radiotherapy for patients with early non-small-cell lung cancer.

Lung Cancer Screening Requires Effective Risk Stratification

Lung Cancer Screening Requires Effective Risk Stratification

Lung cancer screening is more effective and efficient for high-risk individuals.

Lung Cancer Survival May Be Predicted by BMI and Age

Lung Cancer Survival May Be Predicted by BMI and Age

By

Younger age and higher body mass index may be positive predictors of progression-free survival in patients with squamous cell carcinoma of the lung.

Small Cell Lung Cancer: Barriers to Chemotherapy, Radiation

Small Cell Lung Cancer: Barriers to Chemotherapy, Radiation

Lack of insurance correlated with a reduced likelihood of chemotherapy and radiation therapy for small cell lung cancer.

Lack of Communication Regarding Malignancy Risk in Indeterminate Pulmonary Nodules

Lack of Communication Regarding Malignancy Risk in Indeterminate Pulmonary Nodules

By

Qualitative risk statements of malignancy for indeterminate pulmonary nodules are imprecise, highly variable, and should be replaced by a standard scale.

Current Cancer Death Rates in the United States

Current Cancer Death Rates in the United States

The cancer death rate declined by 1.5% annually from 2006 to 2015 in the United States.

Lung Cancer Screening by CT Scan: Risk-Based vs USPSTF Criteria

Lung Cancer Screening by CT Scan: Risk-Based vs USPSTF Criteria

Lung cancer screening based on USPSTF criteria decreased from 2010 to 2015 while risk-targeted screening is associated with modest gains in terms of early lung cancer mortality per person screened.

Measuring Immuno-Oncology Agents Against Cancer Care Framework

Measuring Immuno-Oncology Agents Against Cancer Care Framework

Few modern, US FDA-approved immuno-oncology agents have durable survival and response rates that are deemed significant by the ASCO value framework.

Treatment Disparities in Elderly Patients With Non-Small Cell Lung Cancer

Treatment Disparities in Elderly Patients With Non-Small Cell Lung Cancer

Many octogenarians and nonagenarians with non-small cell lung cancer do not receive cancer-directed care.

Thromboembolic Event Risk With Cisplatin vs Carboplatin in Lung Cancer

Thromboembolic Event Risk With Cisplatin vs Carboplatin in Lung Cancer

By

Platinum-based chemotherapy agents for lung cancer may increase the risk for thromboembolism.

Chemotherapy Followed by Radiotherapy Improves Survival in NSCLC

Chemotherapy Followed by Radiotherapy Improves Survival in NSCLC

By

Adjuvant chemotherapy administered prior to, rather than concurrently with, radiotherapy improves survival outcomes among patients with NSCLC.

Sign Up for Free e-newsletters